KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Capital Expenditures (2016 - 2025)

Biogen has reported Capital Expenditures over the past 17 years, most recently at $43.9 million for Q4 2025.

  • Quarterly results put Capital Expenditures at $43.9 million for Q4 2025, up 11.7% from a year ago — trailing twelve months through Dec 2025 was $153.8 million (changed 0.07% YoY), and the annual figure for FY2025 was $153.8 million, changed 0.07%.
  • Capital Expenditures for Q4 2025 was $43.9 million at Biogen, down from $46.2 million in the prior quarter.
  • Over the last five years, Capital Expenditures for BIIB hit a ceiling of $92.6 million in Q1 2021 and a floor of $26.6 million in Q2 2025.
  • Median Capital Expenditures over the past 5 years was $48.9 million (2021), compared with a mean of $54.1 million.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 92.41% in 2023 and later plummeted 52.83% in 2024.
  • Biogen's Capital Expenditures stood at $51.6 million in 2021, then surged by 67.44% to $86.4 million in 2022, then fell by 24.54% to $65.2 million in 2023, then plummeted by 39.72% to $39.3 million in 2024, then rose by 11.7% to $43.9 million in 2025.
  • The last three reported values for Capital Expenditures were $43.9 million (Q4 2025), $46.2 million (Q3 2025), and $26.6 million (Q2 2025) per Business Quant data.